Topics:

New Company Joins With RPR To Develop Intrabody Technology

New Company Joins With RPR To Develop Intrabody Technology

COLLEGEVILLE, Penn--Intra-immune Therapies, Inc., a new company formed by Dr. Wayne Marasco, of the Dana-Farber Cancer Institute, has joined the Rhône-Poulenc Rorer Gencell network to help accelerate the development of its innovate intrabody, or intracellular antibody, technology.

An intrabody is an engineered human antibody that works inside a cell, offering the potential for blocking molecular changes that can lead to dis-eases such as cancer.

 
Loading comments...

By clicking Accept, you agree to become a member of the UBM Medica Community.